Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

NRG-GY037: A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab Versus Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07061977
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:02.964030+00:00
Published At
2026-04-24T00:00:00+00:00
Record Updated At
2026-04-24
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Locally Advanced Cervical Adenocarcinoma", "Locally Advanced Cervical Adenosquamous Carcinoma", "Locally Advanced Cervical Squamous Cell Carcinoma", "Stage IIIA Cervical Cancer FIGO 2018", "Stage IIIB Cervical Cancer FIGO 2018", "Stage IIIC1 Cervical Cancer FIGO 2018", "Stage IIIC2 Cervical Cancer FIGO 2018", "Stage IVA Cervical Cancer FIGO 2018"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-24"
protocolSection.identificationModule.nctId
"NCT07061977"
protocolSection.identificationModule.officialTitle
"NRG-GY037: A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab Versus Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Locally Advanced Cervical Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Cervical Adenosquamous Carcinoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Cervical Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IIIA Cervical Cancer FIGO 2018 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Cervical Cancer FIGO 2018 (protocolSection.conditionsModule.conditions)
  • Stage IIIC1 Cervical Cancer FIGO 2018 (protocolSection.conditionsModule.conditions)
  • Stage IIIC2 Cervical Cancer FIGO 2018 (protocolSection.conditionsModule.conditions)
  • Stage IVA Cervical Cancer FIGO 2018 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.